Metformin as treatment for overweight and obese adults: a systematic review - Wikidata - thesis-toulmin - TriplyDB

Metformin as treatment for overweight and obese adults: a systematic review

Metformin as treatment for overweight and obese adults: a systematic review

http://www.wikidata.org/entity/Q33224084

about

Metformin and body weight Metformin for obesity or overweight Metformin for women who are obese during pregnancy for improving maternal and infant outcomes Metformin for obesity or overweight Metformin in obesity, cancer and aging: addressing controversies Differential sympathetic outflow to adipose depots is required for visceral fat loss in response to calorie restriction A systematic review on use of Chinese medicine and acupuncture for treatment of obesity.Carbohydrate modified diet & insulin sensitizers reduce body weight & modulate metabolic syndrome measures in EMPOWIR (enhance the metabolic profile of women with insulin resistance): a randomized trial of normoglycemic women with midlife weight gai Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis Bupropion for weight reduction.Role of metformin for weight management in patients without type 2 diabetes.The impact of the metabolic phenotype on thyroid function in obesity.FoxO1 controls lysosomal acid lipase in adipocytes: implication of lipophagy during nutrient restriction and metformin treatment.Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.The effect of antiobesity drugs on waist circumference: a mixed treatment comparison.In this issue: Subtle clinical policy.Practical and Contextual Issues.Metformin Use and Severe Dengue in Diabetic Adults.

P2860

Q22250988-6B52BAE4-1D17-465A-94AB-AED27674F487 Q24195145-3A1DEC97-A4B4-4FD8-91CF-8BBC237E5555 Q24202468-DC81F4AD-629A-43B6-BB09-622EC0242436 Q24236796-63A20F82-0773-4C0B-A13A-F17CEC114B85 Q28480735-AA9DE885-25FA-4B50-A13C-0DAC92C3C5E1 Q30252687-F7AE73BA-A042-4E73-B725-30511050DAD2 Q33686254-A9992F41-D3B6-4353-927A-9B5CE07DD216 Q34258486-F7E321A7-EC55-43FB-BDBE-DDB2E9C6879A Q35114963-D96B9EB1-7252-48D8-993A-7F005D7525B4 Q36691753-6FD747C1-3882-423B-B96E-31D04E20A133 Q37162889-977F417D-4518-4582-A575-0F616751C62A Q37199254-2272F00B-D886-4690-971E-3B64930221A5 Q37577484-B06E89CD-8F11-4C12-9033-59E0E4F7FF0F Q37583856-1943F459-87A7-4233-BAEC-D79F69283B53 Q38130529-A02B59C6-9D9A-4BC0-BF3F-D94E46A0922E Q42434585-66F715FE-F45C-4175-A58E-66B1A27A6D09 Q45815586-4E0D9C03-B0CE-47DE-BEFF-990A35E773F9 Q49789764-783665D5-0CF4-4AFB-91B6-55CD8182E71A

P2860

Metformin as treatment for overweight and obese adults: a systematic review

http://www.wikidata.org/entity/Q33224084

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Metformin as treatment for overweight and obese adults: a systematic review

@ast

Metformin as treatment for overweight and obese adults: a systematic review

@en

type

label

Metformin as treatment for overweight and obese adults: a systematic review

@ast

Metformin as treatment for overweight and obese adults: a systematic review

@en

prefLabel

Metformin as treatment for overweight and obese adults: a systematic review

@ast

Metformin as treatment for overweight and obese adults: a systematic review

@en

P1433

Q33224084-0CE87A79-8250-4013-A11A-059F0496BBA4

P1476

Q33224084-A26A6EAD-B70A-46A9-9EE8-9385BE8958DF

P2093

Q33224084-1FE24177-7AC9-4224-A84B-84772E0437EA

Q33224084-6529101C-9DC4-47F0-BD16-E8D536F24724

Q33224084-755BE955-D33E-48A2-857A-1520DAE136D5

Q33224084-877931B8-B8A6-4660-BB3D-18C85A4E70A7

Q33224084-9518E9D5-3BB2-499E-BF63-A7433A254947

Q33224084-AB66EE28-A107-4535-8522-0E265B94E85A

Q33224084-D495E0A9-1857-482B-B16B-1998E15D0568

P2860

Q33224084-008BDCD4-E0F3-474B-8982-0B5813FA985A

Q33224084-1103A5ED-3025-4171-8C06-62CA87D86247

Q33224084-1A2FACEC-B4F3-426C-A912-9F4DB67ECA04

Q33224084-27E3F549-64DA-49EE-8849-55B9809891D4

Q33224084-32F9D445-8B09-4365-A3DE-652A51D7EF76

Q33224084-3525E96F-09B9-46F8-9CDC-9FDBDD35DA25

Q33224084-35494362-0B66-4DAF-A1C1-EC1DD3146658

Q33224084-38C5D867-68B6-46EB-BF8C-AAC3E98993F5

Q33224084-5D8129FB-4868-4C17-B98F-448C6822650B

Q33224084-7D0291AA-B395-4230-8423-12B3BAF143F5

P304

Q33224084-5A4434D5-FB82-44BF-8A42-6B157B3D604F

P31

Q33224084-5600DDC3-12E9-4A26-948C-F3F6FA100F6C

Q33224084-c726b4f9-81f3-495c-abbf-1078c2c54caf

P356

Q33224084-AC9139FA-88AC-43AD-9F30-895A995FDCF1

P407

Q33224084-1C119BC2-772D-4508-A99F-E6D894598319

P433

Q33224084-AE905D5C-5B96-496E-89E3-1AAAFA3659A3

P478

Q33224084-BB63AB8F-7C45-49B9-A88D-AC83A72A402B

P577

Q33224084-36F321F7-4F00-42B7-890E-D6111B1693F1

P5875

Q33224084-95A1C8D0-B7DD-4623-9D47-9845A7D925DB

P698

Q33224084-A10B608C-1D41-47A4-BA8F-E670F85797D4

P921

Q33224084-B196D04F-4D63-4195-99A8-C25566457840

Q33224084-FA8081B0-4EBC-43B6-B0B0-5EB74FFEB472

P932

Q33224084-F6B33A25-06E6-407E-B1F8-1B8DC2573C44

P356

P1433

Annals of Family Medicine

P1476

Metformin as treatment for overweight and obese adults: a systematic review

@en

P2093

Allen Last

http://www.w3.org/2001/XMLSchema#string

Elizabeth Slaymaker

http://www.w3.org/2001/XMLSchema#string

Frank D'Amico

http://www.w3.org/2001/XMLSchema#string

Jonathan Ference

http://www.w3.org/2001/XMLSchema#string

Julie Yeh

http://www.w3.org/2001/XMLSchema#string

Kara M Levri

http://www.w3.org/2001/XMLSchema#string

Stephen A Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Overweight, obesity, and health risk.

Treatment of binge-eating disorder with topiramate: a clinical case series.

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Long-term pharmacotherapy for obesity and overweight.

Biguanides and NIDDM.

Metabolic effects of metformin in patients with impaired glucose tolerance.

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.

P304

457-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1370/AFM.343

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7575582

http://www.w3.org/2001/XMLSchema#string

P698

16189063

http://www.w3.org/2001/XMLSchema#string

P921

P932

1466911

http://www.w3.org/2001/XMLSchema#string